| Literature DB >> 20003415 |
Stefan Wolf1, Alexander Riess, Julia F Landscheidt, Christianto B Lumenta, Patrick Friederich, Ludwig Schürer.
Abstract
INTRODUCTION: Volumetric parameters acquired by transpulmonary thermodilution had been repeatedly proven superior to filling pressures for estimation of cardiac preload. Up to now, the proposed normal ranges were never studied in detail. We investigated the relationship of the global end-diastolic volume (GEDV) acquired by transpulmonary thermodilution with age and gender in awake and spontaneously breathing patients.Entities:
Mesh:
Year: 2009 PMID: 20003415 PMCID: PMC2811898 DOI: 10.1186/cc8209
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Figure 1Flow of patient recruitment. ICU = intensive care unit; MRI = magnetic resonance imaging; POD = postoperative day.
Preoperative comorbidities and demographic data
| all patients | male | female | ||
|---|---|---|---|---|
| N | 101 | 41 | 60 | |
| Age [years] (range) | 57 (21-83) | 58 (24-79) | 56 (21-83) | 0.314 |
| ASA score (range) | 2 (1-3) | 2 (1-3) | 2 (1-3) | 0.904 |
| Height [cm] (range) | 170 (151-194) | 177 (163-194) | 165 (151-182) | < 0.001 |
| Weight [kg] (range) | 78 (47-125) | 84 (64-125) | 73 (47-120) | < 0.001 |
| BMI [kg/m2] (range) | 26.83 (19.02-43.55) | 27.09 (20.66-39.18) | 26.66 (19.02-43.55) | 0.131 |
| BSA [m2] (range) | 1.73 (1.37-2.19) | 1.88 (1.64-2.19) | 1.63 (1.37-1.93) | < 0.001 |
| PBW [kg] (range) | 63.2 (44.23-87.67) | 72 (59.6-87.67) | 57.2 (44.23-72.3) | 0.195 |
| Glioblastoma | 15 | |||
| Astrocytoma | 11 | |||
| Neurinoma | 6 | |||
| Meningeoma | 27 | |||
| Angioma | 7 | |||
| Metastasis | 16 | |||
| Pituitary | 7 | |||
| Other | 12 | |||
| Hypertension (%) | 31 (30.7) | 12 (29.3) | 19 (31.8) | 0.991 |
| Myocardial infarction (%) | 3 (3.0) | 3 (7.3) | 0 | 0.063 |
| Stroke (%) | 3 (3.0) | 3 (7.3) | 0 | 0.063 |
| Adipositas (%) | 11 (10.9) | 4 (9.8) | 7 (11.8) | 1 |
| Current smoker (%) | 13 (12.9) | 7 (17.1) | 6 (10) | 0.312 |
| ACE inhibitors (%) | 19 (18.8) | 8 (19.5) | 11 (18.3) | 0.927 |
| β-blockers (%) | 18 (17.8) | 8 (19.5) | 10 (16.7) | 0.904 |
| Proton pump inhibitors (%) | 28 (27.7) | 11 (26.8) | 17 (28.3) | 0.932 |
| Anticonvulsives (%) | 19 (18.8) | 6 (14.6) | 13 (21.7) | 0.541 |
| Diuretics (%) | 14 (13.8) | 6 (14.6) | 8 (13.3) | 0.927 |
| Calcium antagonist (%) | 7 (7.0) | 5 (12.2) | 2 (3.3) | 0.115 |
| Steroids (%) | 37 (36.6) | 18 (43.9) | 19 (31.7) | 0.280 |
| Statins (%) | 5 (5.0) | 3 (7.3) | 2 (3.3) | 0.391 |
ACE = angiotensin converting enzyme; ASA = American Society of Anesthesiologists; BMI = body mass index; BSA = body surface area; n = number of patients; PBW = predicted body weight.
Figure 2(a) Global end-diastolic volume (GEDV) and (b) global end-diastolic volume index (GEDVI) versus age in predefined groups (univariate comparison).
Figure 3(a) Global end-diastolic volume (GEDV) and (b) global end-diastolic volume index (GEDVI) versus gender (univariate comparison).
Hemodynamic parameters at discharge from the ICU
| all patients | male | female | |||||
|---|---|---|---|---|---|---|---|
| mean (SD) | n | mean (SD) | n | mean (SD) | n | ||
| 139 (20) | 98 | 141 (20) | 39 | 138 (21) | 59 | 0.559 | |
| 94 (15) | 98 | 96 (16) | 39 | 93 (14) | 59 | 0.324 | |
| 66 (13) | 98 | 68 (14) | 39 | 65 (13) | 59 | 0.141 | |
| 77 (13) | 98 | 74 (14) | 39 | 79 (13) | 59 | 0.074 | |
| 7.16 (1.38) | 101 | 7.55 (1.51) | 41 | 6.78 (1.2) | 60 | 0.004 | |
| 3.81 (0.63) | 101 | 3.93 (0.6) | 41 | 3.82 (0.6) | 60 | 0.890 | |
| 18.5 (0.91) | 101 | 19.5 (0.94) | 41 | 17.9 (0.89) | 60 | 0.05 | |
| 7.37 (0.63) | 101 | 7.38 (0.63) | 41 | 7.36 (0.71) | 60 | 0.3 | |
| 1307 (310) | 101 | 1509 (296) | 41 | 1167 (235) | 60 | < 0.001 | |
| 693 (137) | 101 | 750 (130) | 41 | 653 (128) | 60 | < 0.001 | |
| 1634 (338) | 101 | 1887 (370) | 41 | 1459 (239) | 60 | < 0.001 | |
| 866 (171) | 101 | 938(162) | 41 | 816 (160) | 60 | < 0.001 | |
| 526 (164) | 101 | 533 (97) | 41 | 526 (200) | 60 | 0.80 | |
| 8.5 (3.0) | 101 | 7.4 (1.2) | 41 | 9.3 (3.6) | 60 | < 0.001 | |
| 1072 (517) | 98 | 1035 (485) | 39 | 1097 (539) | 59 | 0.317 | |
| 2001 (921) | 98 | 2054 (829) | 39 | 1965 (983) | 59 | 0.374 | |
| 1743 (1431) | 100 | 1664 (1442) | 41 | 1798 (1447) | 59 | 0.911 | |
Apdia = diastolic arterial pressure; APmean = mean arterial pressure; APsys = systolic arterial pressure; CI = cardiac index; CO = cardiac output; DSt = downslope time; EVLW = extravascular lung water; EVLWI = extravascular lung water index; GEDV = global end-diastolic volume; GEDVI = global end-diastolic volume index; HR = heart rate; ICU = intensive care unit; ITBV = intrathoracic volume; ITBVI = intrathoracic volume index; MTt = mean transit time; n = number of patients; SD = standard deviation; SVR = systemic vessel resistance; SVRI = systemic vessel resistance index.
GEDV and GEDVI according to comorbidities and preoperative medication
| GEDV [ml] | GEDVI [ml/m2] | |||||
|---|---|---|---|---|---|---|
| Comorbidities | yes | no | yes | no | ||
| mean (SD) | mean (SD) | mean (SD) | mean (SD) | |||
| 1384 (288) | 1276 (317) | 0.100 | 717 (140) | 684 (135) | 0.281 | |
| 1660 (172) | 1299 (309) | 0.056 | 810 (69) | 691 (69) | 0.082 | |
| 1754 (224) | 1296 (304) | 0.064 | 866 (101) | 689 (13) | 0.086 | |
| 1378 (261) | 1301 (317) | 0.390 | 650 (87) | 700 (141) | 0.115 | |
| 1252 (255) | 1313 (338) | 0.467 | 659 (91) | 697 (146) | 0.230 | |
| 1441 (304) | 1279 (313) | 0.051 | 719 (144) | 689 (135) | 0.417 | |
| 1389 (256) | 1292 (321) | 0.179 | 725 (140) | 687 (136) | 0.310 | |
| 1240 (239) | 1337 (333) | 0.111 | 665 (100) | 706 (148) | 0.117 | |
| 1223 (263) | 1331 (319) | 0.134 | 666 (128) | 701 (139) | 0.299 | |
| 1426 (332) | 1291 (305) | 0.171 | 690 (133) | 722 (158) | 0.475 | |
| 1571 (338) | 1290 (302) | 0.072 | 788 (168) | 688 (133) | 0.210 | |
| 1375 (378) | 1271 (259) | 0.148 | 723 (163) | 677 (116) | 0.137 | |
| 1619 (305) | 1293 (278) | 0.057 | 849 (124) | 686 (133) | 0.041 | |
ACE = angiotensin converting enzyme; GEDV = global end-diastolic volume; GEDVI = global end-diastolic volume index; SD = standard deviation.
Figure 4(a) Global end-diastolic volume (GEDV) and (b) global end-diastolic volume index (GEDVI) versus age using a generalized additive model. The continuous line represents the highly significant non-linear relationship for all data (P < 0.0001). The dotted and dashed lines show the 95% confidence interval (CI) for females and males. Single data points are shown with male and female symbols.
GEDVI means with 95% confidence intervals for males and females according to age groups
| GEDVI [ml/m2] | ||
|---|---|---|
| 633 (456-880) | 559 (402-779) | |
| 667 (485-916) | 592 (432-812) | |
| 736 (536-1011) | 654 (478-897) | |
| 802 (585-1101) | 713 (520-977) | |
| 812 (590-1117) | 720 (520-997) | |
CI = confidence interval; GEDVI = global end-diastolic volume index